Literature DB >> 6490172

Serratia rubidaea isolated from a silastic foam dressing.

P A Parment, J Ursing, B Palmer.   

Abstract

A pigment-producing strain of Serratia rubidaea was isolated from two consecutive cultures from a sponge of silastic foam used as a dressing for chronic crural ulcers. The bacterium caused a red discolouration of the sponge and the surrounding part of the leg. The silastic sponge creates a new type of environment for microorganisms. The growth of previously rare bacteria such as S. rubidaea may be favoured by conditions within the sponge.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490172     DOI: 10.1007/bf01645958

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Detection of unusual strains of Gram-negative rods through the routine use of a deoxyribonuclease-indole medium.

Authors:  A von Graevenitz
Journal:  Mt Sinai J Med       Date:  1976 Nov-Dec

2.  Foam elastomer dressing in the management of open granulating wounds: experience with 250 patients.

Authors:  R A Wood; R H Williams; L E Hughes
Journal:  Br J Surg       Date:  1977-08       Impact factor: 6.939

Review 3.  The genus Serratia.

Authors:  P A Grimont; F Grimont
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

4.  [Present frequency of the different Serratia species isolated in Grenoble University Hospital Center (author's transl)].

Authors:  J Croize; P Le Noc
Journal:  Pathol Biol (Paris)       Date:  1977-11

5.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

6.  Distribution of Serratia species in clinical specimens.

Authors:  E Johnson; P D Ellner
Journal:  Appl Microbiol       Date:  1974-09
  6 in total
  3 in total

1.  Serratia rubidaea as an invasive pathogen.

Authors:  P R Ursua; M J Unzaga; P Melero; I Iturburu; C Ezpeleta; R Cisterna
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

2.  In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.

Authors:  P Hohl; J Lüthy-Hottenstein; J Zollinger-Iten; M Altwegg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Isolation of Serratia plymuthica from a human burn site.

Authors:  R B Clark; J M Janda
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.